• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类甲状旁腺肿瘤中的表观遗传改变。

Epigenetic alterations in human parathyroid tumors.

作者信息

Verdelli Chiara, Forno Irene, Vaira Valentina, Corbetta Sabrina

机构信息

Laboratory of Molecular Biology, IRCCS Policlinico San Donato, San Donato Milanese, MI, Italy.

出版信息

Endocrine. 2015 Jun;49(2):324-32. doi: 10.1007/s12020-015-0555-4. Epub 2015 Feb 27.

DOI:10.1007/s12020-015-0555-4
PMID:25722013
Abstract

Epigenetics alterations are involved in tumorigenesis and have been identified in endocrine neoplasia. In particular, DNA methylation, microRNAs deregulations and histone methylation impairment are detected in tumors of the parathyroid glands. Parathyroid tumors are the second most common endocrine neoplasia following thyroid cancer in women, and it is associated with primary hyperparathyroidism, a disease sustained by PTH hypersecretion. Despite the hallmark of global promoter hypomethylations was not detectable in parathyroid tumors, increase of hypermethylation in specific CpG islands was detected in the progression from benign to malignant parathyroid tumors. Furthermore, deregulation of a panel of embryonic-related microRNAs (miRNAs) was documented in parathyroid tumors compared with normal glands. Impaired expression of the histone methyltransferases EZH2, BMI1, and RIZ1 have been described in parathyroid tumors. Moreover, histone methyltransferases have been shown to be modulated by the oncosuppressors HIC1, MEN1, and HRPT2/CDC73 gene products that characterize tumorigenesis of parathyroid adenomas and carcinomas, respectively. The epigenetic scenario in parathyroid tumors have just began to be decoded but emerging data highlight the involvement of an embryonic gene signature in parathyroid tumor development.

摘要

表观遗传学改变参与肿瘤发生,并且已在内分泌肿瘤中得到确认。特别是,在甲状旁腺肿瘤中检测到DNA甲基化、微小RNA失调和组蛋白甲基化损伤。甲状旁腺肿瘤是女性继甲状腺癌之后第二常见的内分泌肿瘤,它与原发性甲状旁腺功能亢进有关,原发性甲状旁腺功能亢进是一种由甲状旁腺激素分泌过多引起的疾病。尽管在甲状旁腺肿瘤中未检测到整体启动子低甲基化的特征,但在从良性到恶性甲状旁腺肿瘤的进展过程中,检测到特定CpG岛的高甲基化增加。此外,与正常腺体相比,甲状旁腺肿瘤中一组与胚胎相关的微小RNA(miRNA)失调。在甲状旁腺肿瘤中已描述了组蛋白甲基转移酶EZH2、BMI1和RIZ1的表达受损。此外,组蛋白甲基转移酶已被证明分别受抑癌基因HIC1、MEN1和HRPT2/CDC73基因产物的调节,这些基因产物分别是甲状旁腺腺瘤和癌肿瘤发生的特征。甲状旁腺肿瘤中的表观遗传学情况刚刚开始被解读,但新出现的数据突出了胚胎基因特征在甲状旁腺肿瘤发展中的作用。

相似文献

1
Epigenetic alterations in human parathyroid tumors.人类甲状旁腺肿瘤中的表观遗传改变。
Endocrine. 2015 Jun;49(2):324-32. doi: 10.1007/s12020-015-0555-4. Epub 2015 Feb 27.
2
Alterations of DNA methylation in parathyroid tumors.甲状旁腺肿瘤中的 DNA 甲基化改变。
Mol Cell Endocrinol. 2018 Jul 5;469:60-69. doi: 10.1016/j.mce.2017.05.010. Epub 2017 May 10.
3
Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.抑癌基因 1 (HIC1)在甲状旁腺肿瘤中通过组蛋白 H3 赖氨酸修饰而发生表观遗传学失调控。
J Clin Endocrinol Metab. 2012 Jul;97(7):E1307-15. doi: 10.1210/jc.2011-3136. Epub 2012 Apr 27.
4
Epigenetic Alterations in Parathyroid Cancers.甲状旁腺癌中的表观遗传改变。
Int J Mol Sci. 2017 Feb 1;18(2):310. doi: 10.3390/ijms18020310.
5
Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.非家族性(散发性)甲状旁腺肿瘤的分子遗传学和表观遗传学。
J Intern Med. 2016 Dec;280(6):551-558. doi: 10.1111/joim.12458. Epub 2016 Apr 12.
6
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.CDC73/HRPT2 启动子 CpG 岛甲基化和 5'非翻译区突变是甲状旁腺瘤中抑 parafibromin 的少见机制。
Endocr Relat Cancer. 2010 Feb 18;17(1):273-82. doi: 10.1677/ERC-09-0291. Print 2010 Mar.
7
Histone Modification on Parathyroid Tumors: A Review of Epigenetics.甲状旁腺肿瘤的组蛋白修饰:表观遗传学综述。
Int J Mol Sci. 2022 May 11;23(10):5378. doi: 10.3390/ijms23105378.
8
Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.甲状旁腺肿瘤和嗜铬细胞瘤中RIZ1肿瘤抑制基因的基因内等位基因缺失及启动子高甲基化
Surgery. 2003 Dec;134(6):932-9; discussion 939-40. doi: 10.1016/s0039-6060(03)00422-7.
9
Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的全球和基因特异性启动子甲基化分析。
Epigenetics. 2013 Jun;8(6):646-55. doi: 10.4161/epi.24823. Epub 2013 Jun 13.
10
GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.甲状旁腺腺瘤中 GCM2 的沉默与启动子超甲基化和组蛋白 3 上的甲基化增加有关。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4084-e4096. doi: 10.1210/clinem/dgab374.

引用本文的文献

1
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进的分子和临床谱。
Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009.
2
Common Key Genes in Differentiating Parathyroid Adenoma From Thyroid Adenoma.甲状旁腺腺瘤与甲状腺腺瘤鉴别中的共同关键基因。
Horm Metab Res. 2023 Mar;55(3):212-221. doi: 10.1055/a-2007-2631. Epub 2023 Jan 4.
3
Genetic and Epigenetic Alterations in Parathyroid Neoplasms.甲状旁腺肿瘤中的遗传和表观遗传改变

本文引用的文献

1
FBP1 Is an Interacting Partner of Menin.FBP1是Menin的相互作用蛋白。
Int J Endocrinol. 2014;2014:535401. doi: 10.1155/2014/535401. Epub 2014 Jul 14.
2
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.微小RNA-425-3p可预测肝细胞癌患者对索拉非尼治疗的反应。
Liver Int. 2015 Mar;35(3):1077-86. doi: 10.1111/liv.12636. Epub 2014 Jul 21.
3
Epigenetic alterations in endocrine-related cancer.内分泌相关癌症中的表观遗传改变。
Iran J Pathol. 2022 Fall;17(4):395-405. doi: 10.30699/ijp.2022.551233.2865. Epub 2022 Aug 25.
4
Hypomethylation-mediated overexpression of ITGA2 stimulates cell invasion and migration of thyroid carcinoma.低甲基化介导的 ITGA2 过表达刺激甲状腺癌的细胞侵袭和迁移。
Histol Histopathol. 2023 Jul;38(7):787-796. doi: 10.14670/HH-18-552. Epub 2022 Nov 24.
5
Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors.甲状旁腺肿瘤中异常DNA甲基化的基因组分析
Int J Endocrinol. 2022 Jul 16;2022:4995196. doi: 10.1155/2022/4995196. eCollection 2022.
6
The Activation of Protamine 1 Using Epigenome Editing Decreases the Proliferation of Tumorigenic Cells.使用表观基因组编辑激活鱼精蛋白1可降低致瘤细胞的增殖。
Front Genome Ed. 2022 Jun 16;4:844904. doi: 10.3389/fgeed.2022.844904. eCollection 2022.
7
Histone Modification on Parathyroid Tumors: A Review of Epigenetics.甲状旁腺肿瘤的组蛋白修饰:表观遗传学综述。
Int J Mol Sci. 2022 May 11;23(10):5378. doi: 10.3390/ijms23105378.
8
Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease.慢性肾脏病中甲状旁腺疾病的分子机制
Metabolites. 2022 Jan 25;12(2):111. doi: 10.3390/metabo12020111.
9
MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives.甲状旁腺癌中的微小RNA谱改变:最新进展与展望
Cancers (Basel). 2022 Feb 10;14(4):876. doi: 10.3390/cancers14040876.
10
Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?非编码 RNA 作为甲状旁腺肿瘤发生的有用生物标志物?
Int J Mol Sci. 2021 Sep 28;22(19):10465. doi: 10.3390/ijms221910465.
Endocr Relat Cancer. 2014 Aug;21(4):R319-30. doi: 10.1530/ERC-13-0070. Epub 2014 Jun 4.
4
MicroRNAs: Suggested role in pituitary adenoma pathogenesis.微小 RNA:在垂体腺瘤发病机制中的作用。
J Endocrinol Invest. 2013 Nov;36(10):889-95. doi: 10.1007/BF03346759.
5
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.组蛋白甲基转移酶EZH2,一种在良性和恶性甲状旁腺肿瘤中常见的癌基因。
Endocr Relat Cancer. 2014 Feb 27;21(2):231-9. doi: 10.1530/ERC-13-0497. Print 2014 Apr.
6
MicroRNAs and cancer stem cells: the sword and the shield.微小RNA与癌症干细胞:剑与盾
Oncogene. 2014 Oct 16;33(42):4967-77. doi: 10.1038/onc.2013.492. Epub 2013 Nov 18.
7
MicroRNAs in cancer.微小 RNA 与癌症。
Annu Rev Pathol. 2014;9:287-314. doi: 10.1146/annurev-pathol-012513-104715. Epub 2013 Sep 25.
8
Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的全球和基因特异性启动子甲基化分析。
Epigenetics. 2013 Jun;8(6):646-55. doi: 10.4161/epi.24823. Epub 2013 Jun 13.
9
The clinical and economic burden of a sustained increase in thyroid cancer incidence.甲状腺癌发病率持续增加的临床和经济负担。
Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1252-9. doi: 10.1158/1055-9965.EPI-13-0242. Epub 2013 May 15.
10
Function of oncogenes in cancer development: a changing paradigm.癌基因在癌症发展中的作用:一个不断变化的范式。
EMBO J. 2013 May 29;32(11):1502-13. doi: 10.1038/emboj.2013.97. Epub 2013 Apr 30.